Ganagliflozin not checked

Huadong Medicine

FollowEvery change as it happens, and a Monday email
Next date
Phase 4 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
Makes the kidneys flush extra sugar and salt into the urine. Started as a diabetes drug; now also used for heart and kidney disease.-gliflozin: sodium-glucose co-transporter inhibitors WHO name stem
Tested for
T2DM (Type 2 Diabetes Mellitus) (2 trials), CKD - Chronic Kidney Disease
Main trialPhase 4
“The main objective of this study is to compare the efficacy and safety of the triple combination therapy of Met/SGLT-2i/GLP-1RA or other oral antidiabetic drugs in patients with type 2 diabetes exhibiting poor glycemic control.”In the company’s words, NCT07244003 on ClinicalTrials.gov

Other drugs for T2DM (Type 2 Diabetes Mellitus)

All 128 drugs for T2DM (Type 2 Diabetes Mellitus)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 4Recruiting 31 Dec 2027 Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Phase 4Not yet recruiting 30 Oct 2031 Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Ganagliflozin

Following is part of Solo: you see every change to Ganagliflozin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in